Lindbrook Capital’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $214K | Sell |
16,242
-5,379
| -25% | -$70.9K | 0.02% | 399 |
|
|
2024
Q4 | $341K | Buy |
21,621
+2,311
| +12% | +$36.5K | 0.03% | 287 |
|
|
2024
Q3 | $307K | Sell |
19,310
-1,235
| -6% | -$19.6K | 0.03% | 304 |
|
|
2024
Q2 | $313K | Buy |
20,545
+1,180
| +6% | +$18K | 0.03% | 278 |
|
|
2024
Q1 | $284K | Buy |
19,365
+1,770
| +10% | +$26K | 0.03% | 295 |
|
|
2023
Q4 | $245K | Buy |
17,595
+2,825
| +19% | +$39.3K | 0.02% | 308 |
|
|
2023
Q3 | $198K | Buy |
14,770
+440
| +3% | +$5.89K | 0.02% | 317 |
|
|
2023
Q2 | $181K | Sell |
14,330
-875
| -6% | -$11K | 0.02% | 350 |
|
|
2023
Q1 | $173K | Buy |
15,205
+1,250
| +9% | +$14.2K | 0.02% | 347 |
|
|
2022
Q4 | $144K | Buy |
13,955
+2,415
| +21% | +$25K | 0.02% | 402 |
|
|
2022
Q3 | $121K | Sell |
11,540
-160
| -1% | -$1.68K | 0.02% | 394 |
|
|
2022
Q2 | $130K | Buy |
11,700
+1,720
| +17% | +$19.1K | 0.02% | 389 |
|
|
2022
Q1 | $111K | Buy |
9,980
+2,450
| +33% | +$27.2K | 0.02% | 433 |
|
|
2021
Q4 | $99K | Buy |
7,530
+880
| +13% | +$11.6K | 0.02% | 497 |
|
|
2021
Q3 | $87K | Sell |
6,650
-220
| -3% | -$2.88K | 0.02% | 296 |
|
|
2021
Q2 | $101K | Buy |
6,870
+155
| +2% | +$2.28K | 0.02% | 295 |
|
|
2021
Q1 | $82K | Buy |
6,715
+285
| +4% | +$3.48K | 0.02% | 313 |
|
|
2020
Q4 | $92K | Buy |
6,430
+60
| +0.9% | +$858 | 0.02% | 260 |
|
|
2020
Q3 | $89K | Sell |
6,370
-1,815
| -22% | -$25.4K | 0.02% | 232 |
|
|
2020
Q2 | $87K | Buy |
8,185
+280
| +4% | +$2.98K | 0.03% | 237 |
|
|
2020
Q1 | $64K | Sell |
7,905
-130
| -2% | -$1.05K | 0.02% | 267 |
|
|
2019
Q4 | $65K | Buy |
8,035
+255
| +3% | +$2.06K | 0.02% | 361 |
|
|
2019
Q3 | $59K | Buy |
7,780
+545
| +8% | +$4.13K | 0.02% | 364 |
|
|
2019
Q2 | $54K | Buy |
7,235
+355
| +5% | +$2.65K | 0.02% | 397 |
|
|
2019
Q1 | $55K | Buy |
6,880
+420
| +7% | +$3.36K | 0.02% | 369 |
|
|
2018
Q4 | $48K | Buy |
+6,460
| New | +$48K | 0.02% | 355 |
|